Search for: "Eli Lilly "
Results 141 - 160
of 2,147
Sort by Relevance
|
Sort by Date
16 Aug 2021, 2:15 pm
Court of Appeals for the Federal Circuit today issued two precedential decisions and one nonprecedential decision in cases involving Teva Pharmaceuticals and Eli Lilly, delivering wins and losses for each company. [read post]
16 Aug 2021, 2:15 pm
Court of Appeals for the Federal Circuit today issued two precedential decisions and one nonprecedential decision in cases involving Teva Pharmaceuticals and Eli Lilly, delivering wins and losses for each company. [read post]
26 Jul 2021, 1:23 pm
Eli Lilly & Co. [read post]
16 Jul 2021, 12:53 pm
Eli Lilly & Co., 598 F.3d 1336, 1352 (Fed. [read post]
16 Jul 2021, 12:39 pm
The Fifth Circuit’s recent decision addressed two of those lawsuits brought by relator Health Choice Group, LLC, an NHCA shell company, against Eli Lilly and Bayer. [read post]
13 Jul 2021, 7:41 am
Google, Ford, Yahoo, Hewlett-Packard, Eli Lilly and a number of other prominent corporations have operated or continue to operate a corporate market. [read post]
15 Jun 2021, 9:02 am
That list includes the CEOs of Regeneron ($174 million), Eli Lilly ($68 million), Teladoc ($45 million), UnitedHealth Group ($42 million), and Quest Diagnostics ($34 million).Read 6 remaining paragraphs | Comments [read post]
8 Jun 2021, 9:15 am
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
27 May 2021, 1:36 pm
Indianapolis, Indiana – Eli Lilly and Company (“Lilly”), the Plaintiff, apparently owns by assignment U.S. [read post]
27 May 2021, 1:38 am
Lord Hoffman cited the intervention of trade body the BioIndustry Association in Human Genome Sciences Inc v Eli Lilly and Company [2011] UKSC 51 as an example of a particularly effective intervention. [read post]
17 May 2021, 12:45 am
The DutchKat taking some timein her box to focus on just one thing - the latest half-year patent review (and her pink jingle ball)Last year the IPKat started a series recapping patent litigation in some of the major patent litigation jurisdictions in Europe (see reports from the Netherlands, Germany and France). [read post]
15 May 2021, 5:08 pm
I discussed that judgment in detail in The Supreme Court's Judgment in Eli Lilly v [read post]
20 Apr 2021, 5:10 am
Uruguay [commented by Simon Klopschinski for The IPKat here], Eli Lilly v. [read post]
16 Apr 2021, 12:48 pm
” Citing Eli Lilly & Co. v. [read post]
15 Apr 2021, 1:42 pm
But the pushback of these action dates for AbbVie’s Rinvoq, Pfizer’s Xeljanz and abrocitinib, and Eli Lilly’s Olumiant may be a sign that the FDA is preparing to hold an advisory committee of outside experts to review the risk/benefit profiles of JAK inhibitors for atopic dermatitis, according to Leerink analyst Geoffrey Porges. [read post]
15 Apr 2021, 9:57 am
Samsung, Eli Lilly v. [read post]
1 Apr 2021, 5:14 am
Samsung, Eli Lilly v. [read post]
23 Mar 2021, 1:35 pm
Specifically, besides Xeljanz there are two other JAK inhibitors approved by the FDA: Olumiant (baricitinib) from Eli Lilly & Co.; and, Rinvoq (upadacitinib) from AbbVie. [read post]
10 Mar 2021, 6:38 am
The AP reports that “Eli Lilly said Thursday its COVID-19 antibody drug can prevent illness in residents and staff of nursing homes and other long-term care locations” in “the first major study to show such a treatment may prevent disease. [read post]
27 Feb 2021, 5:21 am
Those who make it to paragraph [307] of the over 500 paragraph judgment are also rewarded with Mr Justice Birss' thought-provoking application of the doctrine of equivalents under Actavis v Eli Lilly ([2017] UKSC 48). [read post]
